‘Series of actions taken to prevent misuse and diversion of codeine-based Phensedyl’: Abbott
“Despite these many efforts, misuse and diversion persisted. That’s why after nearly 70 years on the market, Abbott ceased manufacturing and selling Phensedyl with codeine in December 2024,” it said.
“Despite these many efforts, misuse and diversion persisted. That’s why after nearly 70 years on the market, Abbott ceased manufacturing and selling Phensedyl with codeine in December 2024,” it said.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
